What is FemCap?
FemCap operates at the intersection of medical technology and reproductive health, specializing in the development of a reusable cervical cap crafted from surgical-grade, non-allergenic silicone. The device, characterized by its unique sailor-hat design and flared brim, provides a non-invasive, hormone-free alternative for pregnancy prevention. With clinical data demonstrating over 92% efficacy when paired with spermicide, the company occupies a critical niche for consumers seeking reliable, long-term contraceptive options that avoid the systemic side effects associated with hormonal birth control methods.
How much funding has FemCap raised?
FemCap has raised a total of $17K across 1 funding round:
Debt
$17K
Debt (2021): $17K with participation from PPP
Key Investors in FemCap
PPP
Public-Private Partnership
What's next for FemCap?
With the recent injection of capital, FemCap is poised to transition from its current development phase into a more aggressive market penetration strategy. The firm is expected to prioritize the expansion of its educational outreach and multi-media resources to further validate the safety and efficacy of its device to both clinical practitioners and end-users. As the company navigates the Series A/B growth stage, the focus will likely shift toward optimizing supply chain logistics and broadening distribution channels to ensure wider accessibility of its contraceptive technology in competitive global markets.
See full FemCap company page
